Celularity Inc. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/71ef40a3-b811-41bf-a75c-cad032ff31ba/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $26.6M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-020424 |
| FY 2024 | $54.2M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-009319 |
| FY 2023 | $22.8M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-087886 |
| FY 2022 | $18.0M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011440 |
| FY 2021 | $21.3M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-013004 |
| FY 2020 | $14.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-013004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).